M. Abuelnaga, Youssef Kotb, Waleed Mohamed, Hossam Elawady, Diaa Mostafa
{"title":"肾实质与肾积水面积比在评估儿童输尿管肾盂连接处梗阻中的作用","authors":"M. Abuelnaga, Youssef Kotb, Waleed Mohamed, Hossam Elawady, Diaa Mostafa","doi":"10.4103/ejs.ejs_320_23","DOIUrl":null,"url":null,"abstract":"\n \n For the initial assessment and follow-up of patients with ureteropelvic junction obstruction (UPJO), we conducted this prospective study to assess the renal parenchyma to hydronephrosis area ratio (PHAR) in conjunction with the renal scan in patients who will undergo pyeloplasty.\n \n \n \n Patients who had visited the outpatient clinic for 2 years were diagnosed with UPJO, and fit the requirements for requiring surgical intervention were chosen. Before pyeloplasty and 3 months after surgery, PHAR and a renal isotope scan were conducted concurrently.\n \n \n \n Thirty-six patients were evaluated. After the operation, 31 (86.1%) cases improved and five (13.9%) cases did not improve. There was a significant change in all parameters at 3 months postoperatively as the mean T½ has significantly decreased (25.22±2.49 vs. 17.57±3.84). Also, there was a significant increase in the mean parenchymal thickness (9.42±4.92 vs. 15.12±4.86), glomerular filtration rate of the affected kidney (34.31±3.31 vs. 48.32±6.99) split renal function (37.30±3.80 vs. 44.03 ±4.11) and PHAR (0.86±0.30 vs. 2.45±0.93) at 3 months postoperative. PHAR postoperatively shows a positive correlation with parenchymal thickness, glomerular filtration rate of the affected kidney, and renal split function, while there is a negative correlation with T½.\n \n \n \n PHAR is a potential noninvasive measure that may be evaluated during ultrasonography assessment to aid in predicting future surgical needs for UPJO and for postpyeloplasty follow-up in pediatric patients.\n","PeriodicalId":22550,"journal":{"name":"The Egyptian Journal of Surgery","volume":" 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The role of renal parenchyma to hydronephrosis area ratio in the evaluation of ureteropelvic junction obstruction in children\",\"authors\":\"M. Abuelnaga, Youssef Kotb, Waleed Mohamed, Hossam Elawady, Diaa Mostafa\",\"doi\":\"10.4103/ejs.ejs_320_23\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n \\n For the initial assessment and follow-up of patients with ureteropelvic junction obstruction (UPJO), we conducted this prospective study to assess the renal parenchyma to hydronephrosis area ratio (PHAR) in conjunction with the renal scan in patients who will undergo pyeloplasty.\\n \\n \\n \\n Patients who had visited the outpatient clinic for 2 years were diagnosed with UPJO, and fit the requirements for requiring surgical intervention were chosen. Before pyeloplasty and 3 months after surgery, PHAR and a renal isotope scan were conducted concurrently.\\n \\n \\n \\n Thirty-six patients were evaluated. After the operation, 31 (86.1%) cases improved and five (13.9%) cases did not improve. There was a significant change in all parameters at 3 months postoperatively as the mean T½ has significantly decreased (25.22±2.49 vs. 17.57±3.84). Also, there was a significant increase in the mean parenchymal thickness (9.42±4.92 vs. 15.12±4.86), glomerular filtration rate of the affected kidney (34.31±3.31 vs. 48.32±6.99) split renal function (37.30±3.80 vs. 44.03 ±4.11) and PHAR (0.86±0.30 vs. 2.45±0.93) at 3 months postoperative. PHAR postoperatively shows a positive correlation with parenchymal thickness, glomerular filtration rate of the affected kidney, and renal split function, while there is a negative correlation with T½.\\n \\n \\n \\n PHAR is a potential noninvasive measure that may be evaluated during ultrasonography assessment to aid in predicting future surgical needs for UPJO and for postpyeloplasty follow-up in pediatric patients.\\n\",\"PeriodicalId\":22550,\"journal\":{\"name\":\"The Egyptian Journal of Surgery\",\"volume\":\" 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Egyptian Journal of Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/ejs.ejs_320_23\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Egyptian Journal of Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ejs.ejs_320_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
为了对输尿管肾盂连接处梗阻(UPJO)患者进行初步评估和随访,我们开展了这项前瞻性研究,结合肾脏扫描评估将要接受肾盂成形术的患者的肾实质与肾积水面积比(PHAR)。 研究选择了在门诊就诊 2 年、确诊为 UPJO 并符合手术治疗要求的患者。在肾盂成形术前和术后 3 个月,同时进行 PHAR 和肾同位素扫描。 对 36 名患者进行了评估。手术后,31 例(86.1%)病情好转,5 例(13.9%)病情未好转。术后 3 个月,所有参数均有明显变化,平均 T½ 显著下降(25.22±2.49 vs. 17.57±3.84)。此外,术后 3 个月时,平均肾实质厚度(9.42±4.92 vs. 15.12±4.86)、患肾肾小球滤过率(34.31±3.31 vs. 48.32±6.99)、分裂肾功能(37.30±3.80 vs. 44.03±4.11)和 PHAR(0.86±0.30 vs. 2.45±0.93)均有明显增加。术后 PHAR 与肾实质厚度、患肾肾小球滤过率和肾分裂功能呈正相关,而与 T½ 呈负相关。 PHAR 是一种潜在的无创测量指标,可在超声波检查评估期间进行评估,以帮助预测未来对 UPJO 的手术需求,并对小儿患者进行肾盂成形术后随访。
The role of renal parenchyma to hydronephrosis area ratio in the evaluation of ureteropelvic junction obstruction in children
For the initial assessment and follow-up of patients with ureteropelvic junction obstruction (UPJO), we conducted this prospective study to assess the renal parenchyma to hydronephrosis area ratio (PHAR) in conjunction with the renal scan in patients who will undergo pyeloplasty.
Patients who had visited the outpatient clinic for 2 years were diagnosed with UPJO, and fit the requirements for requiring surgical intervention were chosen. Before pyeloplasty and 3 months after surgery, PHAR and a renal isotope scan were conducted concurrently.
Thirty-six patients were evaluated. After the operation, 31 (86.1%) cases improved and five (13.9%) cases did not improve. There was a significant change in all parameters at 3 months postoperatively as the mean T½ has significantly decreased (25.22±2.49 vs. 17.57±3.84). Also, there was a significant increase in the mean parenchymal thickness (9.42±4.92 vs. 15.12±4.86), glomerular filtration rate of the affected kidney (34.31±3.31 vs. 48.32±6.99) split renal function (37.30±3.80 vs. 44.03 ±4.11) and PHAR (0.86±0.30 vs. 2.45±0.93) at 3 months postoperative. PHAR postoperatively shows a positive correlation with parenchymal thickness, glomerular filtration rate of the affected kidney, and renal split function, while there is a negative correlation with T½.
PHAR is a potential noninvasive measure that may be evaluated during ultrasonography assessment to aid in predicting future surgical needs for UPJO and for postpyeloplasty follow-up in pediatric patients.